“This decision puts us in an even better position to deliver on the promise we made 10 years ago to transform cancer care,” the company said in a statement to the news outlet, noting that the cuts will “better support both our near- and long-term growth as well as our path to profitability.”
The reductions affected such departments as bioinformatics, tech development and account management, according to the Jan. 25 story.
Guardant Health has worked to identify early-stage cancer via blood tests and partnered with Epic on precision oncology EHR integration.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
